TCRT
AlaunosยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TCRT Profile
Alaunos Therapeutics, Inc.
A clinical-stage oncology-focused cell therapy company
2617 Bissonnet Street, Suite 225, Houston, TX 77005
--
Alaunos Therapeutics, Inc., was founded in Delaware. The Company is a clinical-stage oncology-focused cell therapy company focused on developing T cell receptor (TCR) therapies based on its proprietary, non-viral Sleeping Beauty gene transfer platform and its unique cancer mutation hotspot TCR library, targeting common tumor-related mutations in key oncogenes including KRAS, TP53 and EGFR. The company has all clinical and strategic collaborations with the University of Texas MD Anderson Cancer Center and the National Cancer Institute.
